Total Payments
$3,912
2024 Payments
$706.02
Companies
21
Transactions
123
Medicare Patients
20,493
Medicare Billing
$14.7M
Payment Breakdown by Category
Food & Beverage$3,818 (97.6%)
Education$93.64 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,818 | 122 | 97.6% |
| Education | $93.64 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $812.88 | 38 | $0 (2024) |
| Genentech USA, Inc. | $799.86 | 36 | $0 (2024) |
| Glaukos Corporation | $269.50 | 2 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $237.63 | 2 | $0 (2020) |
| Alcon Laboratories Inc | $218.14 | 2 | $0 (2018) |
| ABBVIE INC. | $201.17 | 6 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $159.21 | 3 | $0 (2024) |
| Allergan, Inc. | $149.58 | 10 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $125.00 | 1 | $0 (2024) |
| Alimera Sciences, Inc. | $122.37 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $706.02 | 19 | Regeneron Healthcare Solutions, Inc. ($148.41) |
| 2023 | $687.20 | 22 | Genentech USA, Inc. ($251.84) |
| 2022 | $474.37 | 20 | ABBVIE INC. ($167.32) |
| 2021 | $186.64 | 11 | Regeneron Healthcare Solutions, Inc. ($73.48) |
| 2020 | $167.41 | 4 | Aerie Pharmaceuticals, Inc. ($118.39) |
| 2019 | $700.32 | 15 | Glaukos Corporation ($136.82) |
| 2018 | $474.28 | 16 | Glaukos Corporation ($132.68) |
| 2017 | $515.64 | 16 | Regeneron Healthcare Solutions, Inc. ($149.79) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $115.08 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/03/2024 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 05/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/01/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Ophthalmology | ||||||
| 01/23/2024 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.55 | General |
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/04/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/30/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.85 | General |
| Category: EYE CARE | ||||||
| 11/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/27/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/03/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 5,706 | 27,723 | $13.7M | $4.1M |
| 2022 | 18 | 5,163 | 17,931 | $13.0M | $3.8M |
| 2021 | 18 | 4,771 | 18,392 | $12.2M | $3.7M |
| 2020 | 14 | 4,853 | 16,834 | $10.1M | $3.1M |
Total Patients
20,493
Total Services
80,880
Medicare Billing
$14.7M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 355 | 3,640 | $7.3M | $2.5M | 34.5% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 91 | 1,443 | $1.2M | $313,404 | 27.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 33 | 10,500 | $730,801 | $303,524 | 41.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 510 | 2,170 | $1.6M | $242,544 | 15.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 95 | 871 | $696,800 | $160,985 | 23.1% |
| 92134 | Imaging of retina | Office | 2023 | 1,371 | 3,756 | $638,520 | $135,621 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 775 | 1,235 | $370,500 | $94,465 | 25.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 512 | 926 | $231,500 | $74,247 | 32.1% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 17 | 405 | $121,500 | $48,746 | 40.1% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 22 | 230 | $184,000 | $40,376 | 21.9% |
| J3490 | Unclassified drugs | Office | 2023 | 12 | 22 | $88,000 | $39,511 | 44.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 275 | 302 | $135,900 | $32,691 | 24.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 169 | 169 | $76,050 | $21,122 | 27.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 673 | 969 | $87,210 | $20,463 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $43,200 | $13,506 | 31.3% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 11 | 11 | $88,000 | $12,258 | 13.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 82 | 83 | $24,900 | $10,519 | 42.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 444 | 640 | $54,400 | $8,646 | 15.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 26 | 90 | $45,000 | $4,807 | 10.7% |
| 92250 | Photography of the retina | Office | 2023 | 97 | 120 | $21,000 | $4,142 | 19.7% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 11 | 14 | $22,500 | $2,942 | 13.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,900 | $1,350 | 34.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 16 | 18 | $3,900 | $812.54 | 20.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 298 | 2,890 | $5.8M | $2.1M | 35.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 208 | 4,986 | $4.0M | $1.1M | 27.9% |
About Dr. David Poon, M.D
Dr. David Poon, M.D is a Retina Specialist healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1376861864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Poon, M.D has received a total of $3,912 in payments from pharmaceutical and medical device companies, with $706.02 received in 2024. These payments were reported across 123 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,818).
As a Medicare-enrolled provider, Poon has provided services to 20,493 Medicare beneficiaries, totaling 80,880 services with total Medicare billing of $14.7M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Great Neck, NY
- Active Since 05/10/2010
- Last Updated 09/13/2018
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376861864
Products in Payments
- Vabysmo (Drug) $392.12
- EYLEA (Biological) $382.51
- Lucentis (Biological) $368.97
- OZURDEX (Drug) $255.71
- EYLEA HD (Biological) $239.35
- EYLEA AFLIBERCEPT INJECTION (Biological) $191.02
- ACTHAR (Biological) $144.57
- iStent inject Trabecular Micro-Bypass Stent System (Device) $136.82
- iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $132.68
- ACTIVEFOCUS (Device) $125.06
- MIEBO (Drug) $125.00
- CYSTADROPS (Drug) $122.19
- Cequa (Drug) $122.11
- INVELTYS (Drug) $119.32
- Rhopressa (Drug) $119.24
- rocklatan (Drug) $118.39
- Syfovre (Drug) $115.08
- Cimerli (Biological) $99.63
- DURYSTA (Drug) $95.04
- Centurion (Device) $93.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.